UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

A step forward for LRRK2 inhibitors in Parkinson's disease

Lewis, Patrick A; (2022) A step forward for LRRK2 inhibitors in Parkinson's disease. Science Translational Medicine , 14 (648) , Article eabq7374. 10.1126/scitranslmed.abq7374. Green open access

[thumbnail of abq7374_acceptedversion.pdf]
Preview
 Text
abq7374_acceptedversion.pdf - Accepted Version
Download (994kB) | Preview

Abstract

A phase 1 clinical trial for kinase inhibitors targeting LRRK2 provides the foundation for testing the efficacy of LRRK2 kinase inhibitors in Parkinson’s disease.

Type: Article
Title: A step forward for LRRK2 inhibitors in Parkinson's disease
Open access status: An open access version is available from UCL Discovery
DOI: 10.1126/scitranslmed.abq7374
Publisher version: https://www.science.org/stoken/author-tokens/ST-54...
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Department of Neuromuscular Diseases
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
URI: https://discovery.ucl.ac.uk/id/eprint/10150053
Downloads since deposit
437Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item